GenMark Q4, FY 2012 Revenues Jump Sharply | GenomeWeb

NEW YORK (GenomeWeb News) – GenMark Diagnostics reported after the close of the market Tuesday that its fourth-quarter revenues increased 364 percent year over year, driven by reagent sales from greater system placements.

The Carlsbad, Calif.-based molecular diagnostics firm had total revenues of $9.4 million for the three months ended Dec. 31, compared to $2 million for the fourth quarter of 2011. Its reagent sales were up more than 400 percent to $9.1 million from $1.8 million, while its instrument and other revenues climbed 39 percent to $312,000 from $224,000.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.